FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. FDA ensures that medical countermeasures (MCMs)—including drugs, vaccines and diagnostic tests—to counter these threats are safe, effective, and secure. More: About MCMi and our history
FDA works with government agencies, non-government organizations, universities, and research centers to support public health preparedness and response efforts
Office of Counterterrorism and Emerging Threats (OCET)
OCET coordinates the MCMi, and is part of the FDA Office of the Chief Scientist. Learn more in FDA Organization.
MCM legal, regulatory & policy framework
Helping ensure that U.S. laws, regulations, and policies support preparedness and response for potential CBRN and emerging infectious disease threats.
MCM regulatory science
Developing the tools, standards, and approaches to assess MCM safety, efficacy, quality and performance, and helping translate new technology into innovative, safe, and effective MCMs.
Acting Assistant Commissioner for Counterterrorism Policy, and Acting Director, Office of Counterterrorism and Emerging Threats
For Updates on Twitter follow